K-numberK251520
Device nameCios Alpha; Cios Flow
ApplicantSiemens Medical Solutions USA, Inc.
Product codeOWB
Device classClass II
Decision dateJul 9, 2025
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Cios Alpha and Cios Flow are mobile fluoroscopic C-arm X-ray systems designed to provide real-time X-ray imaging during surgical and interventional procedures. They support applications including orthopedic, vascular, cardiac, gastrointestinal, urologic, neurologic, and pain management procedures, and may be used with pediatric patients.

Technological characteristics

The subject devices (VA31A) incorporate software updated from VA30, an extended NXS interface for InstantLink communication, an updated collimator, a new optional flat-panel detector using IGZO technology (versus amorphous silicon in the predicate), upgraded imaging and graphics processing hardware, and a replacement power supply (Eaton UPS 5P 850i G2). These changes support enhanced functionality while maintaining the same fundamental C-arm geometry and X-ray generation principles.

Test standards cited

Compliance verified against IEC 60601-1 (general electrical safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-2-43 (interventional X-ray equipment safety), IEC 60601-2-54 (radiography/radioscopy equipment), IEC 62304 (medical device software lifecycle), ISO 14971 (risk management), IEC 62366-1 (usability), and DICOM PS 3.1–3.20 (medical imaging standards), among others.

Substantial equivalence argument

The subject devices maintain the same intended use, indications, fundamental operating principle, and C-arm geometry as the predicates (Cios Alpha VA30 and Cios Flow VA30). All hardware and software modifications—including the new detector, updated processors, and software enhancements—were subjected to verification and validation testing that met acceptance criteria and raised no new safety or effectiveness concerns. A clinical cadaver study confirmed the IGZO detector performs non-inferiorly to the predicate amorphous-silicon detector for image quality across four anatomical regions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →